Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants

Objective:  We examined the relationships between long‐term treatment response, side‐effects and drug discontinuation in panic disorder (PD)–agoraphobia.

[1]  H. Verdoux,et al.  Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects , 2003, European Psychiatry.

[2]  W. Katon,et al.  Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder. , 2003, The Journal of clinical psychiatry.

[3]  H. Katschnig,et al.  The long-term course of panic disorder--an 11 year follow-up. , 2003, Journal of anxiety disorders.

[4]  D. Sheehan.  The management of panic disorder. , 2002, The Journal of clinical psychiatry.

[5]  P. Spinhoven,et al.  SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis , 2002, Acta psychiatrica Scandinavica.

[6]  C. Sherbourne,et al.  Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients. , 2002, General hospital psychiatry.

[7]  E. Vieta,et al.  Non‐adherence in psychiatric disorders: misbehaviour or clinical feature? , 2002, Acta psychiatrica Scandinavica.

[8]  Jan Scott,et al.  Treatment non‐adherence in affective disorders , 2002, Acta psychiatrica Scandinavica.

[9]  M. Vasey,et al.  Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. , 2002, Behaviour research and therapy.

[10]  T. Trauer,et al.  The relationship between insight and medication adherence in severely mentally ill clients treated in the community , 2000, Acta psychiatrica Scandinavica.

[11]  J. Os,et al.  Medication adherence in psychosis: predictors and impact on outcome.A 2‐year follow‐up of first‐admitted subjects , 2000, Acta psychiatrica Scandinavica.

[12]  H. Akiskal,et al.  A Prospective Naturalistic Study of 326 Panic-Agoraphobic Patients Treated with Antidepressants , 2000, Pharmacopsychiatry.

[13]  K. Rickels,et al.  Panic disorder: long-term pharmacotherapy and discontinuation. , 1998, Journal of clinical psychopharmacology.

[14]  K. Demyttenaere,et al.  Compliance in depressed patients treated with fluoxetine or amitriptyline , 1998, International clinical psychopharmacology.

[15]  J. Davidson,et al.  The long-term treatment of panic disorder. , 1998, The Journal of clinical psychiatry.

[16]  H. Akiskal,et al.  The semi-structured affective temperament interview (TEMPS-I). Reliability and psychometric properties in 1010 14-26-year old students. , 1998, Journal of affective disorders.

[17]  A. Arntz,et al.  Patient-informant concordance on the Structured Clinical Interview for DSM-III-R personality disorders (SCID-II). , 1998, Journal of personality disorders.

[18]  H. Akiskal,et al.  Delineating a putative phobic-anxious temperament in 126 panic-agoraphobic patients: toward a rapprochement of European and US views. , 1998, Journal of affective disorders.

[19]  S. Hofmann,et al.  Pretreatment attrition in a comparative treatment outcome study on panic disorder. , 1998, The American journal of psychiatry.

[20]  D. Cowley,et al.  Determinants of pharmacologic treatment failure in panic disorder. , 1997, The Journal of clinical psychiatry.

[21]  G. Fava,et al.  Overcoming resistance to exposure in panic disorder with agoraphobia , 1997, Acta psychiatrica Scandinavica.

[22]  K. Demyttenaere.  Compliance during treatment with antidepressants. , 1997, Journal of affective disorders.

[23]  Y. Lecrubier,et al.  Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder , 1997 .

[24]  J. Gorman,et al.  An Algorithm-Oriented Treatment Approach for Panic Disorder , 1996 .

[25]  H. Akiskal,et al.  Psychosensorial and related phenomena in panic disorder and in temporal lobe epilepsy. , 1996, Comprehensive psychiatry.

[26]  G. Klerman,et al.  Long-Term Follow-up after a Drug Trial for Panic Disorder , 1995, British Journal of Psychiatry.

[27]  D. Shera,et al.  Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo , 1994, European Neuropsychopharmacology.

[28]  C. Thompson,et al.  The compliance with antidepressants in general practice , 1994, Journal of psychopharmacology.

[29]  D. Nutt,et al.  Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates , 1994, International clinical psychopharmacology.

[30]  J. L. Ayuso,et al.  Maintenance drug therapy of panic disorder. , 1993, Journal of psychiatric research.

[31]  M. Mavissakalian,et al.  Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. , 1992, Archives of general psychiatry.

[32]  A. Branthwaite,et al.  Out-patient Compliance with Antidepressant Medication , 1992, British Journal of Psychiatry.

[33]  Ryo Oda,et al.  Société Francophone de Primatologie Francophone Primatological Society , 1992 .

[34]  R. Noyes,et al.  Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants. , 1989, Journal of affective disorders.

[35]  D. Young,et al.  Diagnosis of Severely III Inpatients in China: A Collaborative Project Using the Structured Clinical Interview for DSM-III (SCID) , 1988, The Journal of nervous and mental disease.

[36]  N. Andreasen,et al.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. , 1987, Archives of general psychiatry.

[37]  H. Akiskal,et al.  Criteria for the "soft" bipolar spectrum: treatment implications. , 1987, Psychopharmacology bulletin.

[38]  D. A. Johnson.  Depression: Treatment compliance in general practice , 1981, Acta psychiatrica Scandinavica. Supplementum.

[39]  N C Andreasen,et al.  The family history method using diagnostic criteria. Reliability and validity. , 1977, Archives of general psychiatry.